We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+7.67%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$441M
AUM Growth
+$91.2M
(+26%)
Cap. Flow
+$74.5M
Cap. Flow
% of AUM
16.9%
Top 10 Holdings %
Top 10 Hldgs %
24.04%
Holding
1,099
New
222
Increased
266
Reduced
262
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$15.4M |
| 2 |
Stellantis
STLA
|
+$9.9M |
| 3 |
Alcon
ALC
|
+$7.77M |
| 4 |
Amazon
AMZN
|
+$6.64M |
| 5 |
Ferrari
RACE
|
+$5.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Taiwan ETF
EWT
|
+$8.02M |
| 2 |
RSX
VanEck Russia ETF
RSX
|
+$6.88M |
| 3 |
Linde
LIN
|
+$5.74M |
| 4 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$5.13M |
| 5 |
iShares MSCI Turkey ETF
TUR
|
+$4.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.26% |
| 2 | Technology | 13.6% |
| 3 | Financials | 12.86% |
| 4 | Healthcare | 10.91% |
| 5 | Industrials | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Snap-on
SNA
$21.1B
| $91.9K | 0.02% |
411
-165
| -29% | -$39.5K |
|
|
ARNA
552
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $91.9K | 0.02% |
+1,376
| New | +$89.7K |
|
553
Amcor
AMCR
$20.9B
| $90.9K | 0.02% |
1,573
+180
| +13% | +$10.7K |
|
554
Robert Half
RHI
$4.07B
| $90.5K | 0.02% |
1,041
+3
| +0.3% | +$262 |
|
|
LBAI
555
DELISTED
Lakeland Bancorp Inc
LBAI
| $89.7K | 0.02% |
5,422
+1,417
| +35% | +$25.7K |
|
556
Booz Allen Hamilton
BAH
$8.59B
| $89.5K | 0.02% |
+1,008
| New | +$85.2K |
|
557
Western Digital
WDC
$172B
| $88.9K | 0.02% |
1,679
+1,526
| +997% | +$82.5K |
|
558
CRISPR Therapeutics
CRSP
$4.6B
| $88.1K | 0.02% |
650
-13
| -2% | -$1.58K |
|
559
CALL
Logitech
LOGI
$15.5B
| $87.6K | 0.02% |
20
| – | – |
|
560
Mondelez International
MDLZ
$77.9B
| $87.2K | 0.02% |
1,382
+1,359
| +5,909% | +$83.7K |
|
561
Calix
CALX
$2.32B
| $86.8K | 0.02% |
2,024
-578
| -22% | -$25.4K |
|
562
Tradeweb Markets
TW
$21.7B
| $86.1K | 0.02% |
995
+2
| +0.2% | +$163 |
|
563
NRG Energy
NRG
$28.8B
| $86K | 0.02% |
2,116
-11,462
| -84% | -$415K |
|
564
State Street
STT
$50.7B
| $85.2K | 0.02% |
1,019
+68
| +7% | +$5.74K |
|
|
JMIA
565
Jumia Technologies
JMIA
$752M
| $85K | 0.02% |
3,451
| – | – |
|
566
UGI
UGI
$7.91B
| $84.1K | 0.02% |
1,840
-104
| -5% | -$4.68K |
|
567
Roblox
RBLX
$34.7B
| $84K | 0.02% |
1,000
| – | – |
|
568
Hercules Capital
HTGC
$2.95B
| $82.8K | 0.02% |
4,800
-281
| -6% | -$4.81K |
|
|
SCHW
569
Charles Schwab
SCHW
$181B
| $82.6K | 0.02% |
1,150
+9
| +0.8% | +$637 |
|
570
Toll Brothers
TOL
$14.1B
| $82.4K | 0.02% |
1,513
-3,468
| -70% | -$211K |
|
571
Acacia Research
ACTG
$447M
| $81.6K | 0.02% |
+13,440
| New | +$80K |
|
572
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.66B
| $80.4K | 0.02% |
4,489
-9,700
| -68% | -$168K |
|
|
ONC
573
BeOne Medicines Ltd
ONC
$33.8B
| $79K | 0.02% |
239
-126
| -35% | -$41.7K |
|
|
GOEV
574
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $76.1K | 0.02% |
18
| – | – |
|
|
NIU
575
Niu Technologies
NIU
$209M
| $76K | 0.02% |
2,365
| – | – |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2021 Portfolio in Review
As of Q2 2021, Exane Derivatives held 1,099 positions worth $441M, up 26% from $350M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Exane Derivatives deployed $74.5M of net new capital in Q2 2021, opening 222 new positions and adding to 266 existing holdings. Its largest new stake was Alcon: 109,041 shares worth $7.62M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares MSCI Taiwan ETF, an estimated $8.02M trimmed.
- Exane Derivatives's largest Q2 2021 buy was Alcon: 109,041 shares worth $7.62M.
- Exane Derivatives added most to UBS Group in Q2 2021, an estimated $15.4M increase.
- Exane Derivatives's biggest Q2 2021 reduction was iShares MSCI Taiwan ETF, cutting an estimated $8.02M.
- Exane Derivatives fully exited Deutsche Bank in Q2 2021, selling an estimated $4.27M.
- Exane Derivatives's ten largest holdings make up 24% of its $441M portfolio in Q2 2021.
- Exane Derivatives opened 222 new positions and closed 55 in Q2 2021.
- Exane Derivatives's portfolio value rose 26% quarter-over-quarter to $441M.
Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.